MacroGenics Inc
-
Ticker
MGNX
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Rockville, Maryland
MacroGenics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody-based technology platforms.
REPORT RATINGS
4.8 / 5.0 (206)
MacroGenics Inc reports have an aggregate usefulness score of 4.8 based on 206 reviews.
MacroGenics Inc
Most Recent Annual Report
MOST RECENT
2022 Annual Report and Form 10K
Older/Archived Annual Reports